BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36750998)

  • 41. Association of Adjuvant Chemotherapy With Overall Survival Among Patients With Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy.
    Lin JX; Tang YH; Lin GJ; Ma YB; Desiderio J; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Zheng CH; Parisi A; Truty MJ; Huang CM
    JAMA Netw Open; 2022 Apr; 5(4):e225557. PubMed ID: 35363268
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Which is the optimal management for locally advanced gastric cancer patients with TRG 0 and 1 after R0 resection?
    Ma F; Zhang Y; Peng L; Zhang Z; Yang W; Chai J; Zhang B; Ji S; Hua Y; Chen X; Luo S
    Ann Transl Med; 2020 Aug; 8(15):948. PubMed ID: 32953748
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neoadjuvant chemotherapy
    Li Y; Ma FH; Xue LY; Tian YT
    World J Gastroenterol; 2020 Feb; 26(8):818-827. PubMed ID: 32148379
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overview of adjuvant and neoadjuvant therapy for resectable gastric cancer in the East.
    Fujitani K
    Dig Surg; 2013; 30(2):119-29. PubMed ID: 23867588
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toripalimab combined with targeted therapy and chemotherapy achieves pathologic complete response in gastric carcinoma: A case report.
    Liu R; Wang X; Ji Z; Deng T; Li HL; Zhang YH; Yang YC; Ge SH; Zhang L; Bai M; Ning T; Ba Y
    World J Clin Cases; 2022 Jun; 10(18):6184-6191. PubMed ID: 35949814
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neoadjuvant chemotherapy for advanced gastric cancer: a meta-analysis.
    Li W; Qin J; Sun YH; Liu TS
    World J Gastroenterol; 2010 Nov; 16(44):5621-8. PubMed ID: 21105197
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adjuvant therapy for locally advanced gastric cancer.
    Aoyama T; Yoshikawa T
    Surg Today; 2017 Nov; 47(11):1295-1302. PubMed ID: 28251375
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pilot feasibility study of neoadjuvant chemoradiotherapy with S-1 in patients with locally advanced gastric cancer featuring adjacent tissue invasion or JGCA bulky N2 lymph node metastases.
    Inoue T; Yachida S; Usuki H; Kimura T; Hagiike M; Okano K; Suzuki Y
    Ann Surg Oncol; 2012 Sep; 19(9):2937-45. PubMed ID: 22466666
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nomogram for predicting pathological complete response to neoadjuvant chemotherapy in patients with advanced gastric cancer.
    Chen YH; Xiao J; Chen XJ; Wang HS; Liu D; Xiang J; Peng JS
    World J Gastroenterol; 2020 May; 26(19):2427-2439. PubMed ID: 32476803
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Retrospective Study of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer.
    Wang Y; He K; Zhou Z; Zhong Y; Li G; Lu J
    Cancer Manag Res; 2020; 12():8491-8496. PubMed ID: 32982442
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neoadjuvant chemotherapy brings more survival benefits than postoperative chemotherapy for resectable gastric cancer: a Meta-analysis of randomized controlled trials.
    Hu Y; Hu D; Li W; Yu X
    J BUON; 2019; 24(1):201-214. PubMed ID: 30941971
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Posttherapy topographical nodal status, ypN-site, predicts survival of patients who received neoadjuvant chemotherapy followed by curative surgical resection for non-type 4 locally advanced gastric cancer: supplementary analysis of JCOG1004-A.
    Fujitani K; Nakamura K; Mizusawa J; Kuwata T; Shimoda T; Katayama H; Kushima R; Taniguchi H; Yoshikawa T; Boku N; Terashima M; Fukuda H; Sano T; Sasako M;
    Gastric Cancer; 2021 Jan; 24(1):197-204. PubMed ID: 32572792
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of Docetaxel + Oxaliplatin + S-1 vs Oxalipatin + S-1 as Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: A Propensity Score Matched Analysis.
    Zhang X; Huang H; Wei Z; Zhu Z; Yang D; Fu H; Xu J; Hu Z; Zhang Y; You Q; Huang X; Yan R; Wang W; Cai Q
    Cancer Manag Res; 2020; 12():6641-6653. PubMed ID: 32801898
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparisons of effects of SOX and mFOLFOX6 chemotherapy regimens on patients with locally advanced gastric cancer.
    Chen GD; Cao BX; Shi Y; Lv JM; Wang DH; Shi LB
    J Chemother; 2022 Apr; 34(2):117-122. PubMed ID: 34229559
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interpretation of the development of neoadjuvant therapy for gastric cancer based on the vicissitudes of the NCCN guidelines.
    Wang XZ; Zeng ZY; Ye X; Sun J; Zhang ZM; Kang WM
    World J Gastrointest Oncol; 2020 Jan; 12(1):37-53. PubMed ID: 31966912
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Opportunities for Improvement in the Administration of Neoadjuvant Chemotherapy for T4 Breast Cancer: A Comparison of the U.S. and Nigeria.
    Romanoff A; Olasehinde O; Goldman DA; Alatise OI; Constable J; Monu N; Knapp GC; Odujoko O; Onabanjo E; Adisa AO; Arowolo AO; Omisore AD; Famurewa OC; Anderson BO; Gemignani ML; Kingham TP
    Oncologist; 2021 Sep; 26(9):e1589-e1598. PubMed ID: 33955123
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Safety and efficacy of laparoscopic surgery in locally advanced gastric cancer patients with neoadjuvant chemotherapy combined with immunotherapy].
    Lv JB; Yin YP; Zhang P; Cai M; Chen JH; Li W; Li G; Wang Z; Wang GB; Tao KX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jan; 26(1):84-92. PubMed ID: 36650004
    [No Abstract]   [Full Text] [Related]  

  • 58. Reduction of cycles of neoadjuvant chemotherapy for advanced epithelial ovarian, fallopian or primary peritoneal cancer (ROCOCO): study protocol for a phase III randomized controlled trial.
    Park SJ; Shim SH; Ji YI; Kwon SH; Lee EJ; Lee M; Chang SJ; Park S; Kim SY; Lee SJ; Kim JW; Roh JW; Lee SH; Song T; Kim HS
    BMC Cancer; 2020 May; 20(1):385. PubMed ID: 32375688
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Complete Response of Locally Advanced Gastric Cancer with Pancreatic Invasion and Gastric Outlet Obstruction after Neoadjuvant Chemotherapy with S-1 and Oxaliplatin.
    Kondo M; Nishino S; Yamashita D; Kaihara S
    Case Rep Oncol; 2020; 13(2):716-720. PubMed ID: 32774263
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LncRNA BCAR4 expression predicts the clinical response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
    Gan FJ; Li Y; Xu MX; Zhou T; Wu S; Hu K; Li Y; Sun SH; Luo Q
    Cancer Biomark; 2021; 32(3):339-351. PubMed ID: 34151842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.